Stakeholder Identification
In purusing sustainable development, PharmaEngine deeply understands the importance of stakeholder relations and the continuance of our social commitments. We hope to have a transparent and effective communication channel with our stakeholders. We have identified major stakeholder themes using the following six-step procedure:
Major Themes and Boundaries
Major Theme SDGs Management Policy Border Line
Internal External
Innovative R&D SDG8
Decent Work and Economic Growth
  1. Continue to develop competitive and diverse unmet needs drugs
  2. Ensure product quality, safety and compliance
  1. PharmEngine
  2. Employees
  1. Shareholders
  2. Investors
  3. In-license or out-license partners
  4. Customers
  5. Suppliers and CROs
Cyber Security SDG9
Industry, Innovation and Infrastructure
  1. Set up secure information security equipment and management processes
  1. PharmEngine
  2. Employees
  1. Shareholders
  2. Investors
  3. Customers
  4. Suppliers and CROs
Corporate Governance SDG16
Peace, Justice and Strong Institutions
SDG17
Partnerships for the Goals
  1. Incorporate ESG in operation policies
  2. Strengthen the auditing mechanism and strictly prohibit misconduct that endangers the Company
  3. Strengthen internal communication and operation model
  1. PharmEngine
  2. Employees
  1. Shareholders
  2. Investors
  3. Customers
  4. Suppliers and CROs
  5. Government agencies
  6. Media
Industry Cooperation SDG17
Partnerships for the Goals
  1. Drive suppliers or other cooperative units to actively conduct ESG actions
  1. PharmEngine
  2. Employees
  1. Suppliers and CROs
Environment Protection SDG7
Affordable and Clean Energy
SDG12
Responsible Consumption and Production
SDG13
Climate Action
  1. Reduce the waste of energy resources and introduce effective energy and resource improvement equipment or policies
  2. Introduce circular economy to reduce waste
  3. Strengthen the initiatives on climate and environmental issues, and enhance awareness of colleagues and cooperative units
  1. PharmEngine
  2. Employees
  1. Customers
  2. Suppliers and CROs
  3. Communities
  4. Government agencies
Social Engagement SDG3
Good Health and Well-Being
  1. Enhance care for social and human rights issues, and continuously track follow up results
  2. Care for patients and medical institutions, and construct friendly social services
  1. PharmEngine
  2. Employees
  1. Customers
  2. Communities
  3. Charity groups
Employee Training SDG4
Quality Education
SDG8
Decent Work and Economic Growth
SDG10
Reduced Inequalities
  1. Focus on employee career growth and plan a clear functional development blueprint
  2. Protect human rights and create a good working environment
  1. PharmEngine
  2. Employees
  1. Customers
  2. Government agencies
Stakeholder Communication
PharmaEngine's stakeholders include shareholders (investors), employees, in-license or out-license partners, customers, suppliers & CRO, charity groups, communities, government agencies and media. We aim to maintain good relations with stakeholders when promoting various internal and external matters. As the environment continues to evolve and regulations continue to change, we categorize and assign departments to draft action plans for these major topics to increase the flexibility in communicating with stakeholders through cross-department cooperation. To fulfill the expectations of the stakeholders, we communicate via various channels to ensure the action plans have been properly executed and the communication channels to be free from disruptions. The management team also regularly assess the feedback from stakeholders as a reference for future action plans.
Responses and Responsibilities to Stakeholders
To achieve sustainability, we constantly communicate with stakeholders to understand their needs and use that information as reference of the company policy and business development. We listen to the opinion feedback of the stakeholders as a follow-up to improve the subject during the policy and plan implementation process.

We presented and communicated our "Communication with Stakeholders Report" during the Board of Directors meeting on October 31, 2023. The report covered the purpose of communicating with stakeholders, the major topics of borders, major issues concerning stakeholders, identification of and communication with stakeholders, exchanges with stakeholders, and reflections upon and improvements of communication with stakeholders, etc.
Stakeholder Contact Information
Stakeholder Contact Person Telephone E-mail
Shareholders and Investors/Customers/News Media/Government Agencies Corporate Development
ChiHsing Chang, Vice President
(Spokesperson)
(02) 2515-8228 chihsing.chang@pharmaengine.com
Employees/Communities/Charity Groups President & CEO Office, Human Resources
Melody Lin, Director
(02) 2515-8228 melodylin@pharmaengine.com
Partnering Corporate Development
Roger Hsieh, Associate Director
(02) 2515-8228 roger.hsieh@pharmaengine.com
Suppliers and Vendors Marketing & Sales
April Chiu, Associate Director
(02) 2515-8228 april.chiu@pharmaengine.com
Whistleblower Hotline Independent Directors/Audit Office (02) 2515-8228 audit@pharmaengine.com